Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06491758 · ClinicalTrials.gov registry record · NA
ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve
A NA study of Gastroparesis, sponsored by Indiana University.
- Active
- Registry status
- NA
- Development phase
- 131
- Enrollment target
- 1
- Study location
NCT06491758: Active NA study of Gastroparesis, sponsored by Indiana University.
NCT06491758 is a NA study of Gastroparesis that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 131 participants, below the 299-participant average among 44 other Gastroparesis trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06491758, a NA study of Gastroparesis, is active but no longer recruiting, sponsored by Indiana University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out if we can gain access to the vagus nerve which is largely an internal nerve that controls stomach function. We hope to gain access to the internal vagus nerve by electrically stimulating the nerve around the external ear. If we can do this then we hope that this will help our treatment of patients with nausea and vomiting and disordered stomach function
Primary Outcome
To measure the amplitude of vagal nerve compound action potentials during stimulation of the auricular branch of the vagal nerve and during vagal maneuvers.
Conditions Studied
Interventions
- DEVICE ML1101 Stimulus Isolator
- PROCEDURE Vagal Maneuver
Study Locations (1)
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2020-06-02 |
| Est. Completion | 2030-12 |
| Phase | NA |
What the registry record for NCT06491758 still lists
NCT06491758 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, below the 299-participant average among 44 other Gastroparesis trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 2 interventions - of which ML1101 Stimulus Isolator is the first listed.
NCT06491758 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06491758 about?
NCT06491758 is a clinical study titled "ABVN Phase 2-Studying the Effect of Stimulation on the Auricular Branch of the Vagal Nerve". The purpose of this study is to find out if we can gain access to the vagus nerve which is largely an internal nerve that controls stomach function. We hope to gain access to the internal vagus nerve by electrically stimulating the nerve around the external ear. If we can do this then we hope that t...
What is the current status of trial NCT06491758?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 131 participants. The study started on 2020-06-02. Estimated completion is 2030-12.
What conditions does trial NCT06491758 study?
This clinical trial studies the following conditions: Gastroparesis.
What interventions are being tested in trial NCT06491758?
The interventions under investigation include: ML1101 Stimulus Isolator (DEVICE), Vagal Maneuver (PROCEDURE).
Who is sponsoring clinical trial NCT06491758?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06491758 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06491758's enrollment target sits among peer trials
131 17th of 44 higher than 28 of 44 other Gastroparesis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroparesis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients
RECRUITING · NA
-
Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis
RECRUITING · NA
-
Study of Enhanced Programming Stimulation with the Enterra® Therapy System
RECRUITING · NA
-
Study of Enterra Programming with Nocturnal Cycling in Gastroparetics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI